← Open Payments lookup

BOB WINSTON: Open Payments

NPI 1619064367 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$892 in 41 payments from 13 companies in 2025. Trend: 2023 $838 · 2024 $1,308 · 2025 $892

Food & beverage: $892
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.11$193
Alkermes, Inc.3$133
Axsome Therapeutics, Inc.5$110
Otsuka America Pharmaceutical, Inc.4$89
E.R. Squibb & Sons, L.L.C.4$75
Lundbeck LLC3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$53
Janssen Pharmaceuticals, Inc2$43
ABBVIE INC.2$41
Neurocrine BioSciences, Inc.1$28

Products named: FANAPT, REXULTI, LYBALVI, Auvelity, COBENFY, CAPLYTA, ARISTADA, SPRAVATO.

Industry payments across LA — which companies pay providers there.